All stock reports

GLOBALVECT evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

Evidence unavailable

1 opportunity assessments; compare evidence and conditions below.

Event Gap Reaction

Evidence unavailable. Direction: LONG.

Tests whether a material opening gap is accepted rather than immediately rejected

  • Candidate data quality and liquidity must both pass.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Gap fill and reversal below prior close
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-08T23:41:21.356675+00:00

Metrics

latest_annual_period
2026-03-31
revenue
5214090000.0
net_income
-322884000.0
operating_cash_flow
611063000.0
free_cash_flow
191934000.0
total_assets
8881843000.0
total_liabilities
8962874000.0
total_equity
-81031000.0
cash
91292000.0
total_debt
6014043000.0
revenue_growth
-0.038339775952159094
earnings_growth
48.65154544056589
net_margin
-0.06192528322295933
roe
3.9846972146462467
debt_to_equity
-74.21903962680949
cash_conversion
-1.8925155783501195
free_cash_flow_margin
0.03681064193368354
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

Evidence unavailable

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Evidence unavailable. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • Candidate data quality and liquidity must both pass.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
Decision provenance and limitations
Decision ID
decision-a520e29090c3d7eb074efd4c4d8765c968e4d8c22c4c184c949232f81555d39b
Policy
stock-decisions-v1
Evidence bundle hash
f799d119ffd5b4e7391f3555d684b734ad41ee70fb4038d0064d2e644ed1ff87
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 156f9d7093808c756dbf367f529fdcb8c63736531d12ca249c3518df76af854d
  • daily-price: 342aa03816ceccfc7c651e2c1a36a64894b03d0bb52a5d3ba85995332b934eaa
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The cached closing price on 2026-10-01 was INR 131.04. The trailing 5-session price return was -3.57%. The trailing 20-session price return was -8.32%. The trailing 60-session price return was -16.66%. The trailing 250-session price return was -36.55%.

Risks

Average cached traded value over twenty sessions was INR 896,817. The closing price was -46.11% below its highest close in the available trailing year. The cached financial metric revenue growth is -0.038339775952159094. The cached financial metric net margin is -0.06192528322295933. The cached financial metric roe is 3.9846972146462467. The cached financial metric debt to equity is -74.21903962680949.

Follow Up

The cached financial metric cash conversion is -1.8925155783501195. Financial data check: weak_cash_conversion: operating cash flow/net income below 0.5.

Cached observations and evidence limits